Your browser doesn't support javascript.
loading
Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program.
Lim, Lee-Ling; Lau, Eric S H; Kong, Alice P S; Fu, Amy W C; Lau, Vanessa; Jia, Weiping; Sheu, Wayne H H; Sobrepena, Leorino; Yoon, K H; Tan, Alexander T B; Chia, Yook-Chin; Sosale, Aravind; Saboo, Banshi D; Kesavadev, Jothydev; Goh, Su-Yen; Nguyen, Thy Khue; Thewjitcharoen, Yotsapon; Suwita, Raymond; Ma, Ronald C W; Chow, Elaine Y K; Luk, Andrea O Y; Chan, Juliana C N.
Affiliation
  • Lim LL; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Lau ESH; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Kong APS; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.
  • Fu AWC; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Lau V; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.
  • Jia W; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Sheu WHH; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Sobrepena L; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
  • Yoon KH; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.
  • Tan ATB; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.
  • Chia YC; Department of Endocrinology and Metabolism, Shanghai Clinical Centre for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Sosale A; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Saboo BD; Heart of Jesus Hospital, San Jose City, Philippines.
  • Kesavadev J; Department of Endocrinology and Metabolism, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Goh SY; Sunway Medical Centre, Selangor, Malaysia.
  • Nguyen TK; Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Selangor, Malaysia.
  • Thewjitcharoen Y; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Suwita R; Diacon Hospital, Bangalore, India.
  • Ma RCW; Dia Care - Diabetes Care & Hormone Clinic, Gujarat, India.
  • Chow EYK; Jothydev's Diabetes and Research Center, Kerala, India.
  • Luk AOY; Department of Endocrinology, Singapore General Hospital, Singapore.
  • Chan JCN; MEDIC Medical Centre, Ho Chi Minh City, Vietnam.
Lancet Reg Health West Pac ; 32: 100663, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36785858
ABSTRACT

Background:

In Asia, diabetes-associated death due to cardiorenal diseases were 2-3 times higher in women than men which might be due to gender disparity in quality of care and health habits.

Methods:

Adults with type 2 diabetes (T2D) from 11 Asian countries/areas were assessed using the same protocol (2007-2015). We compared treatment target attainment (HbA1c < 7%, blood pressure [BP] < 130/80 mmHg, risk-based LDL-cholesterol, lack of central obesity [waist circumference <90 cm in men or <80 cm in women), use of cardiorenal-protective drugs (renin-angiotensin system [RAS] inhibitors, statins), and self-reported health habits including self-monitoring blood glucose (SMBG) by gender. Analyses were stratified by countries/areas, age of natural menopause (<50 vs. ≥50 years), and comorbidities (atherosclerotic cardiovascular disease [ASCVD], heart failure, kidney impairment [eGFR < 60 mL/min/1.73 m2]).

Findings:

Among 106,376 patients (53.2% men; median (interquartile range) diabetes duration 6.0 (2.0-12.0) years; mean ± SD HbA1c 8.0 ± 1.9%; 27% insulin-treated), women were older and less likely to receive college education than men (28.9% vs. 48.8%). Women were less likely to smoke/drink alcohol and were physically less active than men. Women had lower BP (<130/80 mmHg 29.4% vs. 25.7%), less general obesity (54.8% vs. 57.8%) but more central obesity than men (77.5% vs. 57.3%). Women were less likely to have ASCVD (12.8% vs. 17.0%) or heart failure (1.3% vs. 2.3%), but more likely to have kidney impairment (22.3% vs. 17.6%) and any-site cancer than men (2.5% vs. 1.6%). In most countries/areas, more men attained HbA1c <7% and risk-based LDL-cholesterol level than women. After adjusting for potential confounders including countries and centres, men had 1.63 odds ratio (95% CI 1.51, 1.74) of attaining ≥3 treatment targets than women.

Interpretation:

Asian women with T2D had worse quality of care than men especially in middle-income countries/areas, calling for targeted implementation programs to close these care gaps. Sponsor Asia Diabetes Foundation.

Funding:

Nil.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Evaluation_studies / Guideline / Prevalence_studies / Risk_factors_studies Language: En Journal: Lancet Reg Health West Pac Year: 2023 Type: Article Affiliation country: Malaysia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Evaluation_studies / Guideline / Prevalence_studies / Risk_factors_studies Language: En Journal: Lancet Reg Health West Pac Year: 2023 Type: Article Affiliation country: Malaysia